NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
Back to search
Official data from USPTO
NOLIMIT BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
11/04/2025
Trademark type
Word
Nice classes
42
Filing date
08/22/2023
Registration date
11/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
11/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
01
Owner location
Buenos Aires CABA, AR
Examiner
ABRAMS,JACQUELINE WILLETTE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ACEBAL, ANALIA SILVIA
Representatives
Vivian Ortiz-Ponce PEREZ GUERRERO LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biomedical research services; Pharmaceutical product evaluation; Pharmaceutical products development; Research on the subject of pharmaceuticals; Biotechnology research; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific researchconducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/16/2025
PUBO
PUBLISHED FOR OPPOSITION
09/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/18/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/18/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/24/2025
GNSL
LETTER OF SUSPENSION E-MAILED
04/24/2025
CNSL
SUSPENSION LETTER WRITTEN
04/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2025
ALIE
ASSIGNED TO LIE
04/23/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/31/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/31/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/31/2024
CNSI
SUSPENSION INQUIRY WRITTEN
12/31/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/23/2024
GNSL
LETTER OF SUSPENSION E-MAILED
04/23/2024
CNSL
SUSPENSION LETTER WRITTEN
04/23/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2024
DOCK
ASSIGNED TO EXAMINER
04/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/21/2023
NWAP
NEW APPLICATION ENTERED
08/25/2023
Continuous trademark protection
Get notified about every new filing that threatens NOLIMIT BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.